TABLE 5.
Susceptibility of Candida rugosa to fluconazole and voriconazole by specimen type
| Specimen type/site (total no. of isolates)a | Antifungal agent | No. of isolates tested (%)b | % of isolates from sitec | % of isolates
|
||
|---|---|---|---|---|---|---|
| S | SDD | R | ||||
| Blood (8,256) | Fluconazole | 74 (16.4) | 0.9 | 28.4 | 6.8 | 64.9 |
| Voriconazole | 59 (15.0) | 35.6 | 20.3 | 44.1 | ||
| Urine (9,722) | Fluconazole | 99 (21.9) | 1.0 | 39.4 | 6.1 | 54.5 |
| Voriconazole | 83 (21.1) | 61.4 | 15.7 | 22.9 | ||
| Respiratory (20,274) | Fluconazole | 41 (9.1) | 0.2 | 46.3 | 12.2 | 41.5 |
| Voriconazole | 36 (9.1) | 63.9 | 2.8 | 33.3 | ||
| Skin/soft tissue (4,986) | Fluconazole | 23 (5.1) | 0.5 | 47.8 | 13.0 | 39.1 |
| Voriconazole | 21 (5.3) | 66.7 | 9.5 | 23.8 | ||
| Genital (15,831) | Fluconazole | 20 (4.4) | 0.1 | 75.0 | 10.0 | 15.0 |
| Voriconazole | 12 (3.0) | 100.0 | ||||
| Misc., NOS (16,692) | Fluconazole | 195 (43.1) | 1.2 | 40.0 | 10.3 | 49.7 |
| Voriconazole | 183 (46.5) | 66.1 | 10.9 | 23.0 | ||
a
Total number of Candida isolates from each specimen type.
b
Percentage of all C. rugosa isolates tested.
c
C. rugosa as a percentage of all isolates of that specimen type.